Showing 1,701 - 1,720 results of 2,039 for search '"Rheumatology"', query time: 0.09s Refine Results
  1. 1701
  2. 1702
  3. 1703
  4. 1704
  5. 1705
  6. 1706
  7. 1707
  8. 1708

    Exploring the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality early inflammatory arthritis (EIA) care in England and Wales by Sam Norton, Cath Taylor, James Galloway, Magdalena Zasada, Mark Yates, Nicola Ayers, Zoë Ide

    Published 2021-08-01
    “…Background Evidence from a national clinical audit of early inflammatory arthritis (EIA) shows considerable variability between hospitals in performance, unexplained by controlling for case-mix.Objective To explore the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality EIA care.Methods A qualitative study within 16 purposively sampled rheumatology units across England and Wales. Quality was assessed in relation to 11 quality indicators based on clinical opinion, evidence and variability observed in the data. …”
    Get full text
    Article
  9. 1709
  10. 1710
  11. 1711
  12. 1712
  13. 1713

    Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis by Grace Xiong, BHSc, Eric Yu, Martin Heung, Jaehyeong Yang, BSc, Megan Lowe, MPH, Mohannad Abu-Hilal, MD

    Published 2025-04-01
    “…Oral Janus kinase inhibitors (JAKi) are increasingly used in dermatology, rheumatology, gastroenterology, and hematology. While effective, they can cause adverse effects such as acne, nausea, cytopenia, dyslipidemia, and Herpes zoster. …”
    Get full text
    Article
  14. 1714

    The Pharmacodynamic Impact of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, on Circulating Levels of Inflammatory Biomarkers in Patients with Psoriatic Arthritis: Substudy Res... by Peter H. Schafer, Peng Chen, Lorraine Fang, Andrew Wang, Rajesh Chopra

    Published 2015-01-01
    “…Association between biomarker levels and achievement of 20% improvement from baseline in modified American College of Rheumatology (ACR20) response criteria was assessed by logistic regression. …”
    Get full text
    Article
  15. 1715

    Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signatu... by Raj Tummala, Anna Berglind, Xia Wang, Henk Nab, Barnabas Desta, Edward R Hammond, Farhat Syed

    Published 2020-09-01
    “…Patients ≥18 years old with a physician diagnosis that meets the American College of Rheumatology or Systemic Lupus International Collaborating Clinics SLE classification criteria will be included. …”
    Get full text
    Article
  16. 1716
  17. 1717

    Central Nervous System Involvement in Henoch-Schonlein Purpura in Children and Adolescents by Iliyana H. Pacheva, Ivan S. Ivanov, Krastina Stefanova, Elena Chepisheva, Lyubov Chochkova, Dafina Grozeva, Angelina Stoyanova, Stojan Milenkov, Penka Stefanova, Anna Petrova

    Published 2017-01-01
    “…Diagnosis was based on the American College of Rheumatology criteria. Out of 112 children with HSP 1 case (0.9%) had CNS involvement presenting as Posterior Reversible Encephalopathy Syndrome (PRES), which may be a result of CNS vasculitis or arterial hypertension. …”
    Get full text
    Article
  18. 1718

    Varied Presentations Of Patients With Systemic Lupus Erythematosus – What Makes Pakistani Lupus Patients Different by Muhammad Shahzad Manzoor, Shamaila Mumtaz, Faran Maqbool, Darakhshaan Samar, Muhammad Hammas Adil, Javaria Malik

    Published 2024-03-01
    “…Reasons for serious manifestations at initial presentation include deficiency of healthcare professionals trained in the field of Rheumatology and lack of awareness among patients. …”
    Get full text
    Article
  19. 1719
  20. 1720